Superiority of Gastrojejunostomy Over Endoscopic Stenting for Palliation of Malignant Gastric Outlet Obstruction
- PMID: 30391433
- DOI: 10.1016/j.cgh.2018.10.042
Superiority of Gastrojejunostomy Over Endoscopic Stenting for Palliation of Malignant Gastric Outlet Obstruction
Abstract
Background & aims: Gastric outlet obstruction (GOO) in patients with malignancies causes nausea, vomiting, abdominal pain, malnutrition, and dehydration. Endoscopic placement of self-expandable metallic stent (SEMS) and gastrojejunostomy are the 2 main palliative options. We aimed to compare the outcomes of endoscopic SEMS placement with gastrojejunostomy in a propensity score matched study and identified factors associated with clinical success.
Methods: We performed a retrospective analysis of patients with malignant GOO who underwent endoscopic SEMS placement (n = 183) or gastrojejunostomy (n = 127) from 2011 through 2017 at a tertiary academic medical center. Clinical success was defined as successful resumption of oral intake and relief of obstructive symptoms after either procedure. A propensity score matched analysis was conducted to compare clinical success rate, luminal patency duration, survival length, and adverse outcomes. We performed multivariable analyses to identify factors associated with clinical success.
Results: Proportions of patients with clinical success did not differ significantly between the SMES group (79.4%) and the gastrojejunostomy group (80.1%) (P = .83). The mean patency duration and survival lengths were significantly longer in the gastrojejunostomy group (169.2 and 193.4 days respectively), compared to the endoscopic stenting group (96.5 and 119.9 days respectively). Poor performance status, presence of ascites and low albumin were independent risk factors for failure of enteral stenting and gastrojejunostomy.
Conclusions: In a retrospective analysis of patients with GOO, due to cancer, who underwent endoscopic SEMS placement or gastrojejunostomy, we found gastrojejunostomy to provide significant increases in patency duration and survival time. Gastrojejunostomy should therefore be considered the primary treatment option for patients with good performance status and reasonable survival expectancy. Nutritional status, the absence of ascites, and pre-procedure performance status are associated with clinical success.
Keywords: Endoscopy; Gastric Outlet Obstruction; Gastrojejunostomy; Self-Expandable Metallic Stent.
Copyright © 2019 AGA Institute. Published by Elsevier Inc. All rights reserved.
Comment in
-
Should Patients With Malignant Gastric Outlet Obstruction Receive Stents or Surgery?Clin Gastroenterol Hepatol. 2019 Jun;17(7):1242-1244. doi: 10.1016/j.cgh.2018.11.049. Epub 2018 Nov 29. Clin Gastroenterol Hepatol. 2019. PMID: 30503965 No abstract available.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
